IgA Nephropathy (IgAN), also called Berger’s disease, is a kidney disorder caused by IgA antibody deposits in the glomeruli, leading to inflammation and long-term kidney damage. As medical science advances and awareness spreads, the IgA Nephropathy Market is undergoing significant growth. This article reviews the disease’s epidemiology, evolving therapies, market players, and the future outlook. Read.